These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease. Kolho KL; Sipponen T Scand J Gastroenterol; 2014 Apr; 49(4):434-41. PubMed ID: 24597837 [TBL] [Abstract][Full Text] [Related]
9. Fecal markers: calprotectin and lactoferrin. Abraham BP; Kane S Gastroenterol Clin North Am; 2012 Jun; 41(2):483-95. PubMed ID: 22500530 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers. Ricanek P; Brackmann S; Perminow G; Lyckander LG; Sponheim J; Holme O; Høie O; Rydning A; Vatn MH; Scand J Gastroenterol; 2011 Sep; 46(9):1081-91. PubMed ID: 21619483 [TBL] [Abstract][Full Text] [Related]
13. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease]. van den Bergh FA; Kolkman JJ; Russel MG; Vlaskamp RT; Vermes I Ned Tijdschr Geneeskd; 2003 Nov; 147(48):2360-5. PubMed ID: 14677476 [TBL] [Abstract][Full Text] [Related]
14. Accuracy of four fecal assays in the diagnosis of colitis. Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964 [TBL] [Abstract][Full Text] [Related]
15. Fecal calprotectin is significantly linked to azathioprine metabolite concentrations in Crohn's disease. Essmann J; Keil C; Unruh O; Otte A; Manns MP; Bachmann O Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):99-108. PubMed ID: 30212402 [TBL] [Abstract][Full Text] [Related]
16. Diagnostics and prognostics of inflammatory bowel disease with fecal neutrophil-derived biomarkers calprotectin and lactoferrin. Sipponen T Dig Dis; 2013; 31(3-4):336-44. PubMed ID: 24246984 [TBL] [Abstract][Full Text] [Related]
17. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease. Kolho KL; Raivio T; Lindahl H; Savilahti E Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972 [TBL] [Abstract][Full Text] [Related]
18. Chronic intestinal inflammation and seronegative spondyloarthropathy in children. Conti F; Borrelli O; Anania C; Marocchi E; Romeo EF; Paganelli M; Valesini G; Cucchiara S Dig Liver Dis; 2005 Oct; 37(10):761-7. PubMed ID: 16024303 [TBL] [Abstract][Full Text] [Related]
19. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease. Fagerberg UL; Lööf L; Lindholm J; Hansson LO; Finkel Y J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):414-20. PubMed ID: 18030206 [TBL] [Abstract][Full Text] [Related]
20. Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis. Masoodi I; Kochhar R; Dutta U; Vaishnavi C; Prasad KK; Vaiphei K; Kaur S; Singh K J Gastroenterol Hepatol; 2009 Nov; 24(11):1768-74. PubMed ID: 20136960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]